Skip to main content

Table 1 Anti- Candida activity of the target compounds 5a-k against Candida albicans and Candida tropicalis

From: 1-Aryl-3-(1H-imidazol-1-yl)propan-1-ol esters: synthesis, anti-Candidapotential and molecular modeling studies

Compound no

Candida albicans

Candida tropicalis

 

DIZ ± SD*

MIC (μmol/mL)**

DIZ ± SD*

MIC (μmol/mL)**

5a

17 ± 1.1

0.0833

13 ± 0.9

0.3331

5b

16 ±1.1

0.6662

14 ±1.0

0.3331

5c

16 ±1.0

0.6742

14 ± 0.9

0.3371

5d

14 ± 0.5

0.3523

16 ±1.1

0.3523

5e

16 ±1.6

0.3854

16 ± 0.6

0.3854

5f

16 ± 0.9

0.3902

11 ± 0.9

0.7803

5g

14 ± 0.0

0.6678

14 ± 0.0

0.3339

5h

17 ± 0.9

0.4218

17 ± 0.8

0.4218

5i

14 ± 0.0

0.8134

16 ± 1.0

0.8134

5j

14 ± 0.0

0.8134

19 ± 1.0

0.4067

5k

16 ± 0.6

0.7208

14 ± 0.5

0.3604

Fluconazole

15 ± 0.5

>1.6325

16 ± 0.5

>1.6325

  1. *The arithmetic mean of the inhibition zone diameters in mean ± standard deviation. **The lowest concentration of the compound that produced 50-80% microbial growth inhibition (μmol/mL).